Core Viewpoint - The company has decided to cancel its supervisory board and amend its articles of association to enhance its corporate governance structure, with the supervisory board's responsibilities being transferred to the audit committee of the board [1][2]. Group 1: Board Meeting Details - The 33rd meeting of the 9th Board of Directors was held on July 30, 2025, with all 9 directors present, including some attending via communication [1]. - The meeting's procedures complied with relevant laws and regulations, ensuring the legality and validity of the resolutions made [1]. Group 2: Resolutions Passed - The resolution to cancel the supervisory board and amend the articles of association was passed unanimously with 9 votes in favor, requiring further approval from the shareholders' meeting [2]. - The company also approved the revision of 22 governance documents, including the rules for shareholder meetings and board meetings, with the same unanimous voting outcome [2][3]. - The board approved the nomination of candidates for the 10th Board of Directors, including both non-independent and independent directors, with all resolutions receiving 9 votes in favor [5][6]. Group 3: Upcoming Events - The company plans to hold its third extraordinary shareholders' meeting on August 15, 2025, to review the resolutions passed by the board [6].
太龙药业: 太龙药业第九届董事会第三十三次会议决议公告